NCT01442675View on ClinicalTrials.gov

Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine

PHASE2CompletedINTERVENTIONAL

Enrollment

834

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

December 31, 2012

Conditions

MeningitisMeningococcal Infection

Interventions

BIOLOGICAL

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®

0.5 mL, Intramuscular

Trial Locations (15)

14618

Rochester

18960

Sellersville

23113

Midlothian

37660

Kingsport

40004

Bardstown

41017

Crestview Hills

44121

Cleveland

49120

Niles

49127

Stevensville

72205

Little Rock

84041

Layton

84057

Orem

92103

San Diego

99202

Spokane

01801

Woburn

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01442675 - Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine | Biotech Hunter | Biotech Hunter